Continue Reading... Cannabis Attorney Warns State Operators: Marijuana Schedule III May Not Survive Court Review
Posted in Cannabis Buisness

Cannabis Attorney Warns State Operators: Marijuana Schedule III May Not Survive Court Review

Leading Cannabis Law Firm Harris Sliwoski attorney says operators should proceed “very carefully” and warns agreements may have to stop…

Continue Reading... After the green rush, Oklahoma’s marijuana industry is in freefall
Posted in Cannabis Buisness

After the green rush, Oklahoma’s marijuana industry is in freefall

Some industry players exploited loopholes and lax regulations to develop a vast export market of millions of pounds of illegal…

Continue Reading... Tilray Trades Below $5 With Record Fiscal Revenue on the Books. What’s Holding the Stock Back?
Posted in Cannabis Stocks

Tilray Trades Below $5 With Record Fiscal Revenue on the Books. What’s Holding the Stock Back?

That puts Tilray’s record fiscal 2026 revenues of $915 million into perspective. Coca-Cola made over 13x that in just a…

Continue Reading... Massachusetts Cannabis Repeal Vote Puts Cannabis Banking To The Test
Posted in Cannabis Buisness

Massachusetts Cannabis Repeal Vote Puts Cannabis Banking To The Test

MA voters decide on cannabis legalization repeal in November. Financial services providers are already evaluating the risk. Here’s what industry…

Continue Reading... More than a year later, most recreational cannabis businesses have yet to open in Olmsted County
Posted in Cannabis Buisness

More than a year later, most recreational cannabis businesses have yet to open in Olmsted County

More than a dozen cannabis retailers and dispensaries have yet to open their doors more than a year after Olmsted…

Continue Reading... Green Wednesday 2026: Cannabis Retailers Should Start Planning Now
Posted in Cannabis Buisness

Green Wednesday 2026: Cannabis Retailers Should Start Planning Now

Green Wednesday, cannabis’ Black Friday, falls Nov. 25, 2026. Industry experts explain why retailers should start prepping inventory and marketing…

Continue Reading... Tilray: Schedule III Is Moving Forward, And The Stock Is Still Cheap
Posted in Cannabis Stocks

Tilray: Schedule III Is Moving Forward, And The Stock Is Still Cheap

Tilray Brands stays a Buy as international medical cannabis revenue jumps 34% and U.S. rescheduling is proceeding. Click for why…

Continue Reading... StockTalk | Cannabis report: M&A sparks, insider buys and revenue highs
Posted in Cannabis Stocks

StockTalk | Cannabis report: M&A sparks, insider buys and revenue highs

Our top story in this week’s Cannabis Report centres on Curaleaf (TSX:CURA), which continues to tout the value it would…

Continue Reading... Banks keep cannabis at arm’s length over perceived risk: GAO
Posted in Cannabis Buisness

Banks keep cannabis at arm’s length over perceived risk: GAO

Financial institutions cite an evolving regulatory landscape among reasons for their uncertainty in serving the space, according to a wide-ranging…

Continue Reading... Where Are We on Cannabis Rescheduling? It’s Been Months Since the US Attorney General’s April 2026 Order
Posted in Cannabis Buisness

Where Are We on Cannabis Rescheduling? It’s Been Months Since the US Attorney General’s April 2026 Order

There’s been no transparency about the applications of those seeking DEA registration. The IRS/Treasury has provided no guidance about what…